TW202346573A - 細胞介素相關之腫瘤浸潤性淋巴球組合物及方法 - Google Patents

Info

Publication number

TW202346573A

TW202346573A TW112103170A TW112103170A TW202346573A TW 202346573 A TW202346573 A TW 202346573A TW 112103170 A TW112103170 A TW 112103170A TW 112103170 A TW112103170 A TW 112103170A TW 202346573 A TW202346573 A TW 202346573A

Authority

TW

Taiwan

Prior art keywords

til

population

til population

days

expansion

Prior art date

2022-01-28

Links

• Espacenet
• Global Dossier
• Discuss

• 210000003171 tumor-infiltrating lymphocyte Anatomy 0.000 title claims abstract description 869
• 238000000034 method Methods 0.000 title claims abstract description 403
• 239000000203 mixture Substances 0.000 title claims abstract description 113
• 102000004127 Cytokines Human genes 0.000 title abstract description 3
• 108090000695 Cytokines Proteins 0.000 title abstract description 3
• 206010028980 Neoplasm Diseases 0.000 claims abstract description 245
• 230000002519 immonomodulatory effect Effects 0.000 claims abstract description 213
• 210000004027 cell Anatomy 0.000 claims abstract description 93
• 238000011282 treatment Methods 0.000 claims abstract description 21
• 102000000588 Interleukin-2 Human genes 0.000 claims description 260
• 108010002350 Interleukin-2 Proteins 0.000 claims description 260
• 102000037865 fusion proteins Human genes 0.000 claims description 155
• 108020001507 fusion proteins Proteins 0.000 claims description 155
• 230000003321 amplification Effects 0.000 claims description 140
• 238000003199 nucleic acid amplification method Methods 0.000 claims description 140
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 137
• 210000000612 antigen-presenting cell Anatomy 0.000 claims description 128
• 239000006143 cell culture medium Substances 0.000 claims description 125
• 102000003812 Interleukin-15 Human genes 0.000 claims description 108
• 108090000172 Interleukin-15 Proteins 0.000 claims description 108
• 239000012634 fragment Substances 0.000 claims description 95
• 102000015696 Interleukins Human genes 0.000 claims description 91
• 108010063738 Interleukins Proteins 0.000 claims description 91
• 108010074108 interleukin-21 Proteins 0.000 claims description 84
• 102100030704 Interleukin-21 Human genes 0.000 claims description 83
• 230000027455 binding Effects 0.000 claims description 78
• -1 IFNγ Proteins 0.000 claims description 72
• 230000001225 therapeutic effect Effects 0.000 claims description 70
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 69
• 241000282414 Homo sapiens Species 0.000 claims description 67
• 239000002955 immunomodulating agent Substances 0.000 claims description 63
• 229940121354 immunomodulator Drugs 0.000 claims description 63
• 201000011510 cancer Diseases 0.000 claims description 62
• 108090000623 proteins and genes Proteins 0.000 claims description 61
• 229940047122 interleukins Drugs 0.000 claims description 58
• 238000001802 infusion Methods 0.000 claims description 56
• 238000012258 culturing Methods 0.000 claims description 53
• 102000004169 proteins and genes Human genes 0.000 claims description 53
• 210000000170 cell membrane Anatomy 0.000 claims description 52
• 239000012528 membrane Substances 0.000 claims description 49
• 150000007523 nucleic acids Chemical class 0.000 claims description 49
• 239000000427 antigen Substances 0.000 claims description 48
• 102000036639 antigens Human genes 0.000 claims description 48
• 108091007433 antigens Proteins 0.000 claims description 48
• 238000012546 transfer Methods 0.000 claims description 48
• 102000003810 Interleukin-18 Human genes 0.000 claims description 47
• 108090000171 Interleukin-18 Proteins 0.000 claims description 47
• 238000001574 biopsy Methods 0.000 claims description 45
• 102000039446 nucleic acids Human genes 0.000 claims description 45
• 108020004707 nucleic acids Proteins 0.000 claims description 44
• 108010002586 Interleukin-7 Proteins 0.000 claims description 35
• 229960000106 biosimilars Drugs 0.000 claims description 35
• 239000003795 chemical substances by application Substances 0.000 claims description 35
• 230000007704 transition Effects 0.000 claims description 32
• 230000000977 initiatory effect Effects 0.000 claims description 31
• 230000004048 modification Effects 0.000 claims description 28
• 238000012986 modification Methods 0.000 claims description 28
• 239000013598 vector Substances 0.000 claims description 28
• 108010076504 Protein Sorting Signals Proteins 0.000 claims description 27
• 230000014509 gene expression Effects 0.000 claims description 23
• 230000002584 immunomodulator Effects 0.000 claims description 23
• 229940123189 CD40 agonist Drugs 0.000 claims description 22
• 102000000704 Interleukin-7 Human genes 0.000 claims description 22
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 21
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 21
• 238000013188 needle biopsy Methods 0.000 claims description 21
• 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 claims description 19
• 101000746367 Homo sapiens Granulocyte colony-stimulating factor Proteins 0.000 claims description 19
• 108090001005 Interleukin-6 Proteins 0.000 claims description 19
• 102000004889 Interleukin-6 Human genes 0.000 claims description 19
• 108010002335 Interleukin-9 Proteins 0.000 claims description 19
• 102000000585 Interleukin-9 Human genes 0.000 claims description 19
• 108700012920 TNF Proteins 0.000 claims description 19
• 108020004999 messenger RNA Proteins 0.000 claims description 19
• 108010029697 CD40 Ligand Proteins 0.000 claims description 18
• 102100032937 CD40 ligand Human genes 0.000 claims description 18
• 101001055157 Homo sapiens Interleukin-15 Proteins 0.000 claims description 18
• 101001010621 Homo sapiens Interleukin-21 Proteins 0.000 claims description 18
• 102000056003 human IL15 Human genes 0.000 claims description 18
• 230000008569 process Effects 0.000 claims description 18
• 238000002271 resection Methods 0.000 claims description 18
• 230000001502 supplementing effect Effects 0.000 claims description 18
• 101150013553 CD40 gene Proteins 0.000 claims description 17
• 102000004388 Interleukin-4 Human genes 0.000 claims description 17
• 108090000978 Interleukin-4 Proteins 0.000 claims description 17
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims description 17
• 238000012239 gene modification Methods 0.000 claims description 17
• 239000002105 nanoparticle Substances 0.000 claims description 17
• 210000005105 peripheral blood lymphocyte Anatomy 0.000 claims description 17
• 101001002657 Homo sapiens Interleukin-2 Proteins 0.000 claims description 16
• 210000004698 lymphocyte Anatomy 0.000 claims description 16
• 230000009466 transformation Effects 0.000 claims description 16
• 108091008036 Immune checkpoint proteins Proteins 0.000 claims description 15
• 108010066979 Interleukin-27 Proteins 0.000 claims description 15
• 102100036678 Interleukin-27 subunit alpha Human genes 0.000 claims description 15
• 238000012545 processing Methods 0.000 claims description 15
• 238000002560 therapeutic procedure Methods 0.000 claims description 15
• 230000004913 activation Effects 0.000 claims description 14
• 230000005017 genetic modification Effects 0.000 claims description 14
• 235000013617 genetically modified food Nutrition 0.000 claims description 14
• 108010065637 Interleukin-23 Proteins 0.000 claims description 13
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims description 13
• 239000001963 growth medium Substances 0.000 claims description 12
• 230000001400 myeloablative effect Effects 0.000 claims description 12
• 229960000390 fludarabine Drugs 0.000 claims description 11
• GIUYCYHIANZCFB-FJFJXFQQSA-N fludarabine phosphate Chemical compound C1=NC=2C(N)=NC(F)=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O GIUYCYHIANZCFB-FJFJXFQQSA-N 0.000 claims description 11
• CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 claims description 10
• 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 claims description 10
• 108700025316 aldesleukin Proteins 0.000 claims description 10
• 229960005310 aldesleukin Drugs 0.000 claims description 10
• 229960004397 cyclophosphamide Drugs 0.000 claims description 10
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims description 9
• 239000000556 agonist Substances 0.000 claims description 9
• 238000005138 cryopreservation Methods 0.000 claims description 9
• 230000012010 growth Effects 0.000 claims description 9
• 239000002773 nucleotide Substances 0.000 claims description 9
• 125000003729 nucleotide group Chemical group 0.000 claims description 9
• 230000001177 retroviral effect Effects 0.000 claims description 9
• 101000960954 Homo sapiens Interleukin-18 Proteins 0.000 claims description 8
• 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims description 8
• 102100030698 Interleukin-12 subunit alpha Human genes 0.000 claims description 8
• 102100040678 Programmed cell death protein 1 Human genes 0.000 claims description 8
• 102000043959 human IL18 Human genes 0.000 claims description 8
• 102100036301 C-C chemokine receptor type 7 Human genes 0.000 claims description 7
• 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims description 7
• 101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 claims description 7
• 101710089372 Programmed cell death protein 1 Proteins 0.000 claims description 7
• 229920000642 polymer Polymers 0.000 claims description 7
• 229940122738 CD3 agonist Drugs 0.000 claims description 6
• 108091033409 CRISPR Proteins 0.000 claims description 6
• 102100027377 HBS1-like protein Human genes 0.000 claims description 6
• 101001009070 Homo sapiens HBS1-like protein Proteins 0.000 claims description 6
• 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 claims description 6
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 6
• 238000004520 electroporation Methods 0.000 claims description 6
• 210000005259 peripheral blood Anatomy 0.000 claims description 6
• 239000011886 peripheral blood Substances 0.000 claims description 6
• 238000001890 transfection Methods 0.000 claims description 6
• 239000011701 zinc Substances 0.000 claims description 6
• 229910052725 zinc Inorganic materials 0.000 claims description 6
• 101150043532 CISH gene Proteins 0.000 claims description 5
• 108010021064 CTLA-4 Antigen Proteins 0.000 claims description 5
• 102000008203 CTLA-4 Antigen Human genes 0.000 claims description 5
• 108010007707 Hepatitis A Virus Cellular Receptor 2 Proteins 0.000 claims description 5
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims description 5
• 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 claims description 5
• 102100025390 Integrin beta-2 Human genes 0.000 claims description 5
• 102000017578 LAG3 Human genes 0.000 claims description 5
• 101150030213 Lag3 gene Proteins 0.000 claims description 5
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims description 5
• 108091027967 Small hairpin RNA Proteins 0.000 claims description 5
• 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 5
• 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 5
• 210000000265 leukocyte Anatomy 0.000 claims description 5
• 239000002609 medium Substances 0.000 claims description 5
• 230000001105 regulatory effect Effects 0.000 claims description 5
• 239000004055 small Interfering RNA Substances 0.000 claims description 5
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 4
• 101710149863 C-C chemokine receptor type 4 Proteins 0.000 claims description 4
• 102100035875 C-C chemokine receptor type 5 Human genes 0.000 claims description 4
• 101710149870 C-C chemokine receptor type 5 Proteins 0.000 claims description 4
• 102100036302 C-C chemokine receptor type 6 Human genes 0.000 claims description 4
• 102100028990 C-X-C chemokine receptor type 3 Human genes 0.000 claims description 4
• 102100027207 CD27 antigen Human genes 0.000 claims description 4
• 101000716068 Homo sapiens C-C chemokine receptor type 6 Proteins 0.000 claims description 4
• 101000916050 Homo sapiens C-X-C chemokine receptor type 3 Proteins 0.000 claims description 4
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims description 4
• 101100059511 Homo sapiens CD40LG gene Proteins 0.000 claims description 4
• 101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 claims description 4
• 101001043809 Homo sapiens Interleukin-7 receptor subunit alpha Proteins 0.000 claims description 4
• 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 claims description 4
• 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 claims description 4
• 101001050476 Homo sapiens Tyrosine-protein kinase ITK/TSK Proteins 0.000 claims description 4
• 102100021593 Interleukin-7 receptor subunit alpha Human genes 0.000 claims description 4
• 239000002177 L01XE27 - Ibrutinib Substances 0.000 claims description 4
• 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 claims description 4
• 102100024894 PR domain zinc finger protein 1 Human genes 0.000 claims description 4
• 108010009975 Positive Regulatory Domain I-Binding Factor 1 Proteins 0.000 claims description 4
• 238000012228 RNA interference-mediated gene silencing Methods 0.000 claims description 4
• 208000000102 Squamous Cell Carcinoma of Head and Neck Diseases 0.000 claims description 4
• 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 claims description 4
• 102100023345 Tyrosine-protein kinase ITK/TSK Human genes 0.000 claims description 4
• 239000003937 drug carrier Substances 0.000 claims description 4
• 230000009368 gene silencing by RNA Effects 0.000 claims description 4
• 201000000459 head and neck squamous cell carcinoma Diseases 0.000 claims description 4
• 229960001507 ibrutinib Drugs 0.000 claims description 4
• XYFPWWZEPKGCCK-GOSISDBHSA-N ibrutinib Chemical compound C1=2C(N)=NC=NC=2N([C@H]2CN(CCC2)C(=O)C=C)N=C1C(C=C1)=CC=C1OC1=CC=CC=C1 XYFPWWZEPKGCCK-GOSISDBHSA-N 0.000 claims description 4
• 208000002154 non-small cell lung carcinoma Diseases 0.000 claims description 4
• 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims description 4
• CDKIEBFIMCSCBB-UHFFFAOYSA-N 1-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-3-(1-methyl-2-phenylpyrrolo[2,3-b]pyridin-3-yl)prop-2-en-1-one;hydrochloride Chemical compound Cl.C1C=2C=C(OC)C(OC)=CC=2CCN1C(=O)C=CC(C1=CC=CN=C1N1C)=C1C1=CC=CC=C1 CDKIEBFIMCSCBB-UHFFFAOYSA-N 0.000 claims description 3
• 102100034614 Ankyrin repeat domain-containing protein 11 Human genes 0.000 claims description 3
• 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 claims description 3
• 102100021247 BCL-6 corepressor Human genes 0.000 claims description 3
• 102100022970 Basic leucine zipper transcriptional factor ATF-like Human genes 0.000 claims description 3
• 101000964894 Bos taurus 14-3-3 protein zeta/delta Proteins 0.000 claims description 3
• 102100024263 CD160 antigen Human genes 0.000 claims description 3
• 108090000397 Caspase 3 Proteins 0.000 claims description 3
• 102100026549 Caspase-10 Human genes 0.000 claims description 3
• 102100029855 Caspase-3 Human genes 0.000 claims description 3
• 102100038918 Caspase-6 Human genes 0.000 claims description 3
• 102100038902 Caspase-7 Human genes 0.000 claims description 3
• 102100026548 Caspase-8 Human genes 0.000 claims description 3
• 102100027816 Cytotoxic and regulatory T-cell molecule Human genes 0.000 claims description 3
• 101000809594 Escherichia coli (strain K12) Shikimate kinase 1 Proteins 0.000 claims description 3
• 102100026693 FAS-associated death domain protein Human genes 0.000 claims description 3
• 102100027581 Forkhead box protein P3 Human genes 0.000 claims description 3
• 102100040754 Guanylate cyclase soluble subunit alpha-1 Human genes 0.000 claims description 3
• 102100040735 Guanylate cyclase soluble subunit alpha-2 Human genes 0.000 claims description 3
• 102100040739 Guanylate cyclase soluble subunit beta-1 Human genes 0.000 claims description 3
• 102100028963 Guanylate cyclase soluble subunit beta-2 Human genes 0.000 claims description 3
• 102100028008 Heme oxygenase 2 Human genes 0.000 claims description 3
• 102100035081 Homeobox protein TGIF1 Human genes 0.000 claims description 3
• 101000824278 Homo sapiens Acyl-[acyl-carrier-protein] hydrolase Proteins 0.000 claims description 3
• 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 claims description 3
• 101000903742 Homo sapiens Basic leucine zipper transcriptional factor ATF-like Proteins 0.000 claims description 3
• 101000761938 Homo sapiens CD160 antigen Proteins 0.000 claims description 3
• 101000983518 Homo sapiens Caspase-10 Proteins 0.000 claims description 3
• 101000741087 Homo sapiens Caspase-6 Proteins 0.000 claims description 3
• 101000741014 Homo sapiens Caspase-7 Proteins 0.000 claims description 3
• 101000983528 Homo sapiens Caspase-8 Proteins 0.000 claims description 3
• 101000911074 Homo sapiens FAS-associated death domain protein Proteins 0.000 claims description 3
• 101000861452 Homo sapiens Forkhead box protein P3 Proteins 0.000 claims description 3
• 101001038755 Homo sapiens Guanylate cyclase soluble subunit alpha-1 Proteins 0.000 claims description 3
• 101001038749 Homo sapiens Guanylate cyclase soluble subunit alpha-2 Proteins 0.000 claims description 3
• 101001038731 Homo sapiens Guanylate cyclase soluble subunit beta-1 Proteins 0.000 claims description 3
• 101001059095 Homo sapiens Guanylate cyclase soluble subunit beta-2 Proteins 0.000 claims description 3
• 101001079615 Homo sapiens Heme oxygenase 2 Proteins 0.000 claims description 3
• 101000596925 Homo sapiens Homeobox protein TGIF1 Proteins 0.000 claims description 3
• 101001083151 Homo sapiens Interleukin-10 receptor subunit alpha Proteins 0.000 claims description 3
• 101001003149 Homo sapiens Interleukin-10 receptor subunit beta Proteins 0.000 claims description 3
• 101000599048 Homo sapiens Interleukin-6 receptor subunit alpha Proteins 0.000 claims description 3
• 101000599056 Homo sapiens Interleukin-6 receptor subunit beta Proteins 0.000 claims description 3
• 101001138062 Homo sapiens Leukocyte-associated immunoglobulin-like receptor 1 Proteins 0.000 claims description 3
• 101000653374 Homo sapiens Methylcytosine dioxygenase TET2 Proteins 0.000 claims description 3
• 101000884270 Homo sapiens Natural killer cell receptor 2B4 Proteins 0.000 claims description 3
• 101001091194 Homo sapiens Peptidyl-prolyl cis-trans isomerase G Proteins 0.000 claims description 3
• 101000692259 Homo sapiens Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 Proteins 0.000 claims description 3
• 101001068027 Homo sapiens Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform Proteins 0.000 claims description 3
• 101001068019 Homo sapiens Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform Proteins 0.000 claims description 3
• 101000863882 Homo sapiens Sialic acid-binding Ig-like lectin 7 Proteins 0.000 claims description 3
• 101000863883 Homo sapiens Sialic acid-binding Ig-like lectin 9 Proteins 0.000 claims description 3
• 101000688930 Homo sapiens Signaling threshold-regulating transmembrane adapter 1 Proteins 0.000 claims description 3
• 101000863692 Homo sapiens Ski oncogene Proteins 0.000 claims description 3
• 101000688996 Homo sapiens Ski-like protein Proteins 0.000 claims description 3
• 101000740162 Homo sapiens Sodium- and chloride-dependent transporter XTRP3 Proteins 0.000 claims description 3
• 101000596234 Homo sapiens T-cell surface protein tactile Proteins 0.000 claims description 3
• 101000648265 Homo sapiens Thymocyte selection-associated high mobility group box protein TOX Proteins 0.000 claims description 3
• 101000610604 Homo sapiens Tumor necrosis factor receptor superfamily member 10B Proteins 0.000 claims description 3
• 101000922131 Homo sapiens Tyrosine-protein kinase CSK Proteins 0.000 claims description 3
• 101001135589 Homo sapiens Tyrosine-protein phosphatase non-receptor type 22 Proteins 0.000 claims description 3
• 101000617285 Homo sapiens Tyrosine-protein phosphatase non-receptor type 6 Proteins 0.000 claims description 3
• 101000926525 Homo sapiens eIF-2-alpha kinase GCN2 Proteins 0.000 claims description 3
• 102100022339 Integrin alpha-L Human genes 0.000 claims description 3
• 101710123016 Integrin alpha-L Proteins 0.000 claims description 3
• 102000003814 Interleukin-10 Human genes 0.000 claims description 3
• 108090000174 Interleukin-10 Proteins 0.000 claims description 3
• 102100030236 Interleukin-10 receptor subunit alpha Human genes 0.000 claims description 3
• 102100020788 Interleukin-10 receptor subunit beta Human genes 0.000 claims description 3
• 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 claims description 3
• 102100037795 Interleukin-6 receptor subunit beta Human genes 0.000 claims description 3
• 102100020943 Leukocyte-associated immunoglobulin-like receptor 1 Human genes 0.000 claims description 3
• 102100030803 Methylcytosine dioxygenase TET2 Human genes 0.000 claims description 3
• 102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 claims description 3
• 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 claims description 3
• 102100025748 Mothers against decapentaplegic homolog 3 Human genes 0.000 claims description 3
• 101710143111 Mothers against decapentaplegic homolog 3 Proteins 0.000 claims description 3
• 102100025725 Mothers against decapentaplegic homolog 4 Human genes 0.000 claims description 3
• 101710143112 Mothers against decapentaplegic homolog 4 Proteins 0.000 claims description 3
• 102100038082 Natural killer cell receptor 2B4 Human genes 0.000 claims description 3
• 102100026066 Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 Human genes 0.000 claims description 3
• 102100034464 Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform Human genes 0.000 claims description 3
• 102100034470 Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform Human genes 0.000 claims description 3
• 102100029946 Sialic acid-binding Ig-like lectin 7 Human genes 0.000 claims description 3
• 102100029965 Sialic acid-binding Ig-like lectin 9 Human genes 0.000 claims description 3
• 102100024453 Signaling threshold-regulating transmembrane adapter 1 Human genes 0.000 claims description 3
• 102100029969 Ski oncogene Human genes 0.000 claims description 3
• 102100024451 Ski-like protein Human genes 0.000 claims description 3
• 101150045565 Socs1 gene Proteins 0.000 claims description 3
• 108700027336 Suppressor of Cytokine Signaling 1 Proteins 0.000 claims description 3
• 102100024779 Suppressor of cytokine signaling 1 Human genes 0.000 claims description 3
• 101000987219 Sus scrofa Pregnancy-associated glycoprotein 1 Proteins 0.000 claims description 3
• 101001045447 Synechocystis sp. (strain PCC 6803 / Kazusa) Sensor histidine kinase Hik2 Proteins 0.000 claims description 3
• 102100035268 T-cell surface protein tactile Human genes 0.000 claims description 3
• 108091007178 TNFRSF10A Proteins 0.000 claims description 3
• 102100028788 Thymocyte selection-associated high mobility group box protein TOX Human genes 0.000 claims description 3
• 102100040113 Tumor necrosis factor receptor superfamily member 10A Human genes 0.000 claims description 3
• 102100040112 Tumor necrosis factor receptor superfamily member 10B Human genes 0.000 claims description 3
• 102100031167 Tyrosine-protein kinase CSK Human genes 0.000 claims description 3
• 102100033138 Tyrosine-protein phosphatase non-receptor type 22 Human genes 0.000 claims description 3
• 102100021657 Tyrosine-protein phosphatase non-receptor type 6 Human genes 0.000 claims description 3
• 108010072917 class-I restricted T cell-associated molecule Proteins 0.000 claims description 3
• 102100034175 eIF-2-alpha kinase GCN2 Human genes 0.000 claims description 3
• 201000001441 melanoma Diseases 0.000 claims description 3
• 230000009467 reduction Effects 0.000 claims description 3
• 239000007787 solid Substances 0.000 claims description 3
• 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims description 2
• 102100022718 Atypical chemokine receptor 2 Human genes 0.000 claims description 2
• 102100038080 B-cell receptor CD22 Human genes 0.000 claims description 2
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims description 2
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims description 2
• 206010005003 Bladder cancer Diseases 0.000 claims description 2
• 206010006187 Breast cancer Diseases 0.000 claims description 2
• 208000026310 Breast neoplasm Diseases 0.000 claims description 2
• 102100031172 C-C chemokine receptor type 1 Human genes 0.000 claims description 2
• 101710149814 C-C chemokine receptor type 1 Proteins 0.000 claims description 2
• 102100031151 C-C chemokine receptor type 2 Human genes 0.000 claims description 2
• 101710149815 C-C chemokine receptor type 2 Proteins 0.000 claims description 2
• 102100036305 C-C chemokine receptor type 8 Human genes 0.000 claims description 2
• 102100028989 C-X-C chemokine receptor type 2 Human genes 0.000 claims description 2
• 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims description 2
• 102100031658 C-X-C chemokine receptor type 5 Human genes 0.000 claims description 2
• 108090000835 CX3C Chemokine Receptor 1 Proteins 0.000 claims description 2
• 102100039196 CX3C chemokine receptor 1 Human genes 0.000 claims description 2
• 206010008342 Cervix carcinoma Diseases 0.000 claims description 2
• 102000006354 HLA-DR Antigens Human genes 0.000 claims description 2
• 108010058597 HLA-DR Antigens Proteins 0.000 claims description 2
• 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims description 2
• 101000678892 Homo sapiens Atypical chemokine receptor 2 Proteins 0.000 claims description 2
• 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims description 2
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 2
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims description 2
• 101000777558 Homo sapiens C-C chemokine receptor type 10 Proteins 0.000 claims description 2
• 101000716063 Homo sapiens C-C chemokine receptor type 8 Proteins 0.000 claims description 2
• 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 claims description 2
• 101000922405 Homo sapiens C-X-C chemokine receptor type 5 Proteins 0.000 claims description 2
• 101000633778 Homo sapiens SLAM family member 5 Proteins 0.000 claims description 2
• 101001018021 Homo sapiens T-lymphocyte surface antigen Ly-9 Proteins 0.000 claims description 2
• 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 claims description 2
• 241000701806 Human papillomavirus Species 0.000 claims description 2
• 108010018951 Interleukin-8B Receptors Proteins 0.000 claims description 2
• 208000008839 Kidney Neoplasms Diseases 0.000 claims description 2
• 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 2
• XOGTZOOQQBDUSI-UHFFFAOYSA-M Mesna Chemical compound [Na+].[O-]S(=O)(=O)CCS XOGTZOOQQBDUSI-UHFFFAOYSA-M 0.000 claims description 2
• RRHONYZEMUNMJX-UHFFFAOYSA-N N-[5-[[5-[(4-acetyl-1-piperazinyl)-oxomethyl]-4-methoxy-2-methylphenyl]thio]-2-thiazolyl]-4-[(3-methylbutan-2-ylamino)methyl]benzamide Chemical compound C1=C(C(=O)N2CCN(CC2)C(C)=O)C(OC)=CC(C)=C1SC(S1)=CN=C1NC(=O)C1=CC=C(CNC(C)C(C)C)C=C1 RRHONYZEMUNMJX-UHFFFAOYSA-N 0.000 claims description 2
• 102100023181 Neurogenic locus notch homolog protein 1 Human genes 0.000 claims description 2
• 108700037638 Neurogenic locus notch homolog protein 1 Proteins 0.000 claims description 2
• 101800001731 Notch 2 intracellular domain Proteins 0.000 claims description 2
• 102400000545 Notch 2 intracellular domain Human genes 0.000 claims description 2
• 101710163270 Nuclease Proteins 0.000 claims description 2
• 206010033128 Ovarian cancer Diseases 0.000 claims description 2
• 206010061535 Ovarian neoplasm Diseases 0.000 claims description 2
• 206010038389 Renal cancer Diseases 0.000 claims description 2
• 208000006265 Renal cell carcinoma Diseases 0.000 claims description 2
• 102100029216 SLAM family member 5 Human genes 0.000 claims description 2
• 102100033447 T-lymphocyte surface antigen Ly-9 Human genes 0.000 claims description 2
• 208000003721 Triple Negative Breast Neoplasms Diseases 0.000 claims description 2
• 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 claims description 2
• 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims description 2
• 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims description 2
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 2
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 2
• 230000003213 activating effect Effects 0.000 claims description 2
• 230000003115 biocidal effect Effects 0.000 claims description 2
• 229920001400 block copolymer Polymers 0.000 claims description 2
• 125000002091 cationic group Chemical group 0.000 claims description 2
• 229920006317 cationic polymer Polymers 0.000 claims description 2
• 201000010881 cervical cancer Diseases 0.000 claims description 2
• 230000030279 gene silencing Effects 0.000 claims description 2
• 201000010536 head and neck cancer Diseases 0.000 claims description 2
• 208000014829 head and neck neoplasm Diseases 0.000 claims description 2
• 230000036039 immunity Effects 0.000 claims description 2
• 239000003112 inhibitor Substances 0.000 claims description 2
• 201000010982 kidney cancer Diseases 0.000 claims description 2
• 239000003446 ligand Substances 0.000 claims description 2
• 239000002502 liposome Substances 0.000 claims description 2
• 201000005202 lung cancer Diseases 0.000 claims description 2
• 208000020816 lung neoplasm Diseases 0.000 claims description 2
• 229960004635 mesna Drugs 0.000 claims description 2
• 239000008194 pharmaceutical composition Substances 0.000 claims description 2
• 208000022679 triple-negative breast carcinoma Diseases 0.000 claims description 2
• 229940121358 tyrosine kinase inhibitor Drugs 0.000 claims description 2
• 201000005112 urinary bladder cancer Diseases 0.000 claims description 2
• 102000013462 Interleukin-12 Human genes 0.000 claims 32
• 108010065805 Interleukin-12 Proteins 0.000 claims 32
• 238000010354 CRISPR gene editing Methods 0.000 claims 4
• 102100030703 Interleukin-22 Human genes 0.000 claims 3
• 102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 claims 2
• 229940045513 CTLA4 antagonist Drugs 0.000 claims 2
• 101710083479 Hepatitis A virus cellular receptor 2 homolog Proteins 0.000 claims 2
• 102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 claims 2
• 229940126547 T-cell immunoglobulin mucin-3 Drugs 0.000 claims 2
• 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 claims 1
• 101000924476 Homo sapiens Ankyrin repeat domain-containing protein 11 Proteins 0.000 claims 1
• 101100165236 Homo sapiens BCOR gene Proteins 0.000 claims 1
• 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 claims 1
• 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 claims 1
• 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 claims 1
• 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 claims 1
• 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 claims 1
• 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 claims 1
• 230000000259 anti-tumor effect Effects 0.000 abstract description 7
• 230000004083 survival effect Effects 0.000 abstract description 7
• 230000003308 immunostimulating effect Effects 0.000 abstract description 6
• 230000035755 proliferation Effects 0.000 abstract description 4
• 238000011275 oncology therapy Methods 0.000 abstract description 3
• 125000005647 linker group Chemical group 0.000 description 78
• 235000018102 proteins Nutrition 0.000 description 52
• 108090000765 processed proteins & peptides Proteins 0.000 description 39
• 235000001014 amino acid Nutrition 0.000 description 36
• 210000004379 membrane Anatomy 0.000 description 27
• 102100035360 Cerebellar degeneration-related antigen 1 Human genes 0.000 description 26
• 239000000523 sample Substances 0.000 description 26
• 239000002202 Polyethylene glycol Substances 0.000 description 23
• 229920001223 polyethylene glycol Polymers 0.000 description 23
• 238000006467 substitution reaction Methods 0.000 description 20
• 229940024606 amino acid Drugs 0.000 description 19
• 150000001413 amino acids Chemical class 0.000 description 18
• 201000010099 disease Diseases 0.000 description 17
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
• 108060003951 Immunoglobulin Proteins 0.000 description 16
• 239000003814 drug Substances 0.000 description 16
• 102000018358 immunoglobulin Human genes 0.000 description 16
• 239000000047 product Substances 0.000 description 16
• 239000002253 acid Substances 0.000 description 14
• 230000001640 apoptogenic effect Effects 0.000 description 14
• 229940079593 drug Drugs 0.000 description 14
• 230000013595 glycosylation Effects 0.000 description 14
• 238000006206 glycosylation reaction Methods 0.000 description 14
• 229920001184 polypeptide Polymers 0.000 description 14
• 102000004196 processed proteins & peptides Human genes 0.000 description 14
• 229920002477 rna polymer Polymers 0.000 description 14
• 210000001519 tissue Anatomy 0.000 description 13
• 229940126601 medicinal product Drugs 0.000 description 12
• 210000003071 memory t lymphocyte Anatomy 0.000 description 12
• 239000000562 conjugate Substances 0.000 description 10
• 239000012636 effector Substances 0.000 description 10
• 108020005176 AU Rich Elements Proteins 0.000 description 9
• 108020004414 DNA Proteins 0.000 description 9
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 9
• 230000000694 effects Effects 0.000 description 9
• 230000004927 fusion Effects 0.000 description 9
• 210000004602 germ cell Anatomy 0.000 description 9
• 108010047041 Complementarity Determining Regions Proteins 0.000 description 8
• 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 description 8
• 108091008874 T cell receptors Proteins 0.000 description 8
• 238000001727 in vivo Methods 0.000 description 8
• 102000005962 receptors Human genes 0.000 description 8
• 108020003175 receptors Proteins 0.000 description 8
• 229920003169 water-soluble polymer Polymers 0.000 description 8
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 7
• 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 7
• 208000002250 Hematologic Neoplasms Diseases 0.000 description 7
• 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 7
• 239000008186 active pharmaceutical agent Substances 0.000 description 7
• 125000000539 amino acid group Chemical group 0.000 description 7
• 210000003719 b-lymphocyte Anatomy 0.000 description 7
• 210000004369 blood Anatomy 0.000 description 7
• 239000008280 blood Substances 0.000 description 7
• 150000001875 compounds Chemical class 0.000 description 7
• 230000003834 intracellular effect Effects 0.000 description 7
• 230000002829 reductive effect Effects 0.000 description 7
• 229960002317 succinimide Drugs 0.000 description 7
• 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 description 6
• 102000013264 Interleukin-23 Human genes 0.000 description 6
• 239000000306 component Substances 0.000 description 6
• 102000055277 human IL2 Human genes 0.000 description 6
• 239000007788 liquid Substances 0.000 description 6
• 208000024891 symptom Diseases 0.000 description 6
• 102000004190 Enzymes Human genes 0.000 description 5
• 108090000790 Enzymes Proteins 0.000 description 5
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 5
• 239000004472 Lysine Substances 0.000 description 5
• 108091028043 Nucleic acid sequence Proteins 0.000 description 5
• 108010073062 Transcription Activator-Like Effectors Proteins 0.000 description 5
• 238000002659 cell therapy Methods 0.000 description 5
• KZNICNPSHKQLFF-UHFFFAOYSA-N dihydromaleimide Natural products O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 5
• 229940088598 enzyme Drugs 0.000 description 5
• 150000004676 glycans Chemical class 0.000 description 5
• 229940072221 immunoglobulins Drugs 0.000 description 5
• 239000000463 material Substances 0.000 description 5
• 230000014616 translation Effects 0.000 description 5
• 229910052720 vanadium Inorganic materials 0.000 description 5
• 108090000663 Annexin A1 Proteins 0.000 description 4
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
• 102100034235 ELAV-like protein 1 Human genes 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 4
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 4
• 102000014150 Interferons Human genes 0.000 description 4
• 108010050904 Interferons Proteins 0.000 description 4
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
• SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 4
• 241001465754 Metazoa Species 0.000 description 4
• 241000699666 Mus <mouse, genus> Species 0.000 description 4
• 206010035226 Plasma cell myeloma Diseases 0.000 description 4
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
• 102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 description 4
• 150000001412 amines Chemical class 0.000 description 4
• 150000001720 carbohydrates Chemical class 0.000 description 4
• 235000014633 carbohydrates Nutrition 0.000 description 4
• 238000002512 chemotherapy Methods 0.000 description 4
• XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
• 238000005516 engineering process Methods 0.000 description 4
• 230000006870 function Effects 0.000 description 4
• 229910052739 hydrogen Inorganic materials 0.000 description 4
• 210000000987 immune system Anatomy 0.000 description 4
• 229940079322 interferon Drugs 0.000 description 4
• 238000004519 manufacturing process Methods 0.000 description 4
• 230000006320 pegylation Effects 0.000 description 4
• 239000000546 pharmaceutical excipient Substances 0.000 description 4
• 238000002360 preparation method Methods 0.000 description 4
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
• 210000003289 regulatory T cell Anatomy 0.000 description 4
• 210000002966 serum Anatomy 0.000 description 4
• 241000894007 species Species 0.000 description 4
• 238000013519 translation Methods 0.000 description 4
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
• VILFTWLXLYIEMV-UHFFFAOYSA-N 1,5-difluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC([N+]([O-])=O)=C(F)C=C1F VILFTWLXLYIEMV-UHFFFAOYSA-N 0.000 description 3
• 102100026802 72 kDa type IV collagenase Human genes 0.000 description 3
• FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 3
• 241000699802 Cricetulus griseus Species 0.000 description 3
• 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 3
• 108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 3
• SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
• PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 3
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
• 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 description 3
• 108010075704 HLA-A Antigens Proteins 0.000 description 3
• 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 description 3
• 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 description 3
• 101001019455 Homo sapiens ICOS ligand Proteins 0.000 description 3
• 101001018097 Homo sapiens L-selectin Proteins 0.000 description 3
• 101001063392 Homo sapiens Lymphocyte function-associated antigen 3 Proteins 0.000 description 3
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 3
• 102100034980 ICOS ligand Human genes 0.000 description 3
• 102100033467 L-selectin Human genes 0.000 description 3
• 102100030984 Lymphocyte function-associated antigen 3 Human genes 0.000 description 3
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 3
• 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 3
• 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 3
• 241001529936 Murinae Species 0.000 description 3
• 108010018525 NFATC Transcription Factors Proteins 0.000 description 3
• 102000002673 NFATC Transcription Factors Human genes 0.000 description 3
• OJYRJTUKEXSKOS-ZETCQYMHSA-N N[C@@H](CCCCNOCCN=[N+]=[N-])C(O)=O Chemical compound N[C@@H](CCCCNOCCN=[N+]=[N-])C(O)=O OJYRJTUKEXSKOS-ZETCQYMHSA-N 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 3
• 210000004241 Th2 cell Anatomy 0.000 description 3
• 238000007792 addition Methods 0.000 description 3
• 238000013475 authorization Methods 0.000 description 3
• 229940121413 bempegaldesleukin Drugs 0.000 description 3
• 230000004071 biological effect Effects 0.000 description 3
• 229960000074 biopharmaceutical Drugs 0.000 description 3
• 238000004422 calculation algorithm Methods 0.000 description 3
• 238000004113 cell culture Methods 0.000 description 3
• 238000012217 deletion Methods 0.000 description 3
• 230000037430 deletion Effects 0.000 description 3
• 210000004443 dendritic cell Anatomy 0.000 description 3
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 3
• 238000011161 development Methods 0.000 description 3
• 230000018109 developmental process Effects 0.000 description 3
• 229940126534 drug product Drugs 0.000 description 3
• 239000013604 expression vector Substances 0.000 description 3
• 238000009472 formulation Methods 0.000 description 3
• 239000012595 freezing medium Substances 0.000 description 3
• 238000003144 genetic modification method Methods 0.000 description 3
• 238000010362 genome editing Methods 0.000 description 3
• 201000005787 hematologic cancer Diseases 0.000 description 3
• 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 3
• 230000001506 immunosuppresive effect Effects 0.000 description 3
• 238000000338 in vitro Methods 0.000 description 3
• 208000032839 leukemia Diseases 0.000 description 3
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
• 231100000350 mutagenesis Toxicity 0.000 description 3
• 201000000050 myeloid neoplasm Diseases 0.000 description 3
• 210000000822 natural killer cell Anatomy 0.000 description 3
• 210000001672 ovary Anatomy 0.000 description 3
• 239000000825 pharmaceutical preparation Substances 0.000 description 3
• 230000009261 transgenic effect Effects 0.000 description 3
• 239000013603 viral vector Substances 0.000 description 3
• FXYPGCIGRDZWNR-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-[[3-(2,5-dioxopyrrolidin-1-yl)oxy-3-oxopropyl]disulfanyl]propanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCSSCCC(=O)ON1C(=O)CCC1=O FXYPGCIGRDZWNR-UHFFFAOYSA-N 0.000 description 2
• PMJWDPGOWBRILU-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 4-[4-(2,5-dioxopyrrol-1-yl)phenyl]butanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCCC(C=C1)=CC=C1N1C(=O)C=CC1=O PMJWDPGOWBRILU-UHFFFAOYSA-N 0.000 description 2
• RBAFCMJBDZWZIV-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 4-azido-2-hydroxybenzoate Chemical compound OC1=CC(N=[N+]=[N-])=CC=C1C(=O)ON1C(=O)CCC1=O RBAFCMJBDZWZIV-UHFFFAOYSA-N 0.000 description 2
• LWAVGNJLLQSNNN-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 4-azidobenzoate Chemical compound C1=CC(N=[N+]=[N-])=CC=C1C(=O)ON1C(=O)CCC1=O LWAVGNJLLQSNNN-UHFFFAOYSA-N 0.000 description 2
• KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
• GAJBPZXIKZXTCG-VIFPVBQESA-N (2s)-2-amino-3-[4-(azidomethyl)phenyl]propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(CN=[N+]=[N-])C=C1 GAJBPZXIKZXTCG-VIFPVBQESA-N 0.000 description 2
• AXKGIPZJYUNAIW-UHFFFAOYSA-N (4-aminophenyl)methanol Chemical compound NC1=CC=C(CO)C=C1 AXKGIPZJYUNAIW-UHFFFAOYSA-N 0.000 description 2
• GERXSZLDSOPHJV-UHFFFAOYSA-N (4-nitrophenyl) 2-iodoacetate Chemical compound [O-][N+](=O)C1=CC=C(OC(=O)CI)C=C1 GERXSZLDSOPHJV-UHFFFAOYSA-N 0.000 description 2
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
• AASYSXRGODIQGY-UHFFFAOYSA-N 1-[1-(2,5-dioxopyrrol-1-yl)hexyl]pyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C(CCCCC)N1C(=O)C=CC1=O AASYSXRGODIQGY-UHFFFAOYSA-N 0.000 description 2
• CALIYGMVBZRBLV-UHFFFAOYSA-N 2-(4-azidophenyl)-2-oxoacetaldehyde Chemical compound [N-]=[N+]=NC1=CC=C(C(=O)C=O)C=C1 CALIYGMVBZRBLV-UHFFFAOYSA-N 0.000 description 2
• YHJZWYNRTYKWEC-UHFFFAOYSA-N 2-diazonio-3,3,3-trifluoro-1-(4-nitrophenoxy)prop-1-en-1-olate Chemical compound [O-][N+](=O)C1=CC=C(OC(=O)C(=[N+]=[N-])C(F)(F)F)C=C1 YHJZWYNRTYKWEC-UHFFFAOYSA-N 0.000 description 2
• 108020005345 3' Untranslated Regions Proteins 0.000 description 2
• DJBRKGZFUXKLKO-UHFFFAOYSA-N 3-(pyridin-2-yldisulfanyl)propanoic acid Chemical compound OC(=O)CCSSC1=CC=CC=N1 DJBRKGZFUXKLKO-UHFFFAOYSA-N 0.000 description 2
• 108010082808 4-1BB Ligand Proteins 0.000 description 2
• 206010000871 Acute monocytic leukaemia Diseases 0.000 description 2
• 102100021266 Alpha-(1,6)-fucosyltransferase Human genes 0.000 description 2
• 101710188804 Ankyrin repeat domain-containing protein 11 Proteins 0.000 description 2
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 2
• 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 2
• 102100037853 C-C chemokine receptor type 4 Human genes 0.000 description 2
• 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 2
• 102000036364 Cullin Ring E3 Ligases Human genes 0.000 description 2
• 108091007045 Cullin Ring E3 Ligases Proteins 0.000 description 2
• 108010016626 Dipeptides Proteins 0.000 description 2
• 102100035273 E3 ubiquitin-protein ligase CBL-B Human genes 0.000 description 2
• 108010019236 Fucosyltransferases Proteins 0.000 description 2
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical class C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
• NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
• 101000894690 Homo sapiens BCL-6 corepressor Proteins 0.000 description 2
• 101000737265 Homo sapiens E3 ubiquitin-protein ligase CBL-B Proteins 0.000 description 2
• 101001002709 Homo sapiens Interleukin-4 Proteins 0.000 description 2
• 101001043807 Homo sapiens Interleukin-7 Proteins 0.000 description 2
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 2
• OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
• 229920001612 Hydroxyethyl starch Polymers 0.000 description 2
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
• 108700005091 Immunoglobulin Genes Proteins 0.000 description 2
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 2
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 2
• 108010038498 Interleukin-7 Receptors Proteins 0.000 description 2
• 102000010782 Interleukin-7 Receptors Human genes 0.000 description 2
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
• 108010016165 Matrix Metalloproteinase 2 Proteins 0.000 description 2
• 108010052285 Membrane Proteins Proteins 0.000 description 2
• 102000018697 Membrane Proteins Human genes 0.000 description 2
• 206010027476 Metastases Diseases 0.000 description 2
• 208000035489 Monocytic Acute Leukemia Diseases 0.000 description 2
• 108700031757 NKTR-214 Proteins 0.000 description 2
• 108091005461 Nucleic proteins Proteins 0.000 description 2
• 240000007019 Oxalis corniculata Species 0.000 description 2
• 102000035195 Peptidases Human genes 0.000 description 2
• 108091005804 Peptidases Proteins 0.000 description 2
• DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 241000700159 Rattus Species 0.000 description 2
• 108010092262 T-Cell Antigen Receptors Proteins 0.000 description 2
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 2
• 102000040945 Transcription factor Human genes 0.000 description 2
• 108091023040 Transcription factor Proteins 0.000 description 2
• 108700019146 Transgenes Proteins 0.000 description 2
• 102100032101 Tumor necrosis factor ligand superfamily member 9 Human genes 0.000 description 2
• 108091023045 Untranslated Region Proteins 0.000 description 2
• DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
• 239000002671 adjuvant Substances 0.000 description 2
• 102000012086 alpha-L-Fucosidase Human genes 0.000 description 2
• 108010061314 alpha-L-Fucosidase Proteins 0.000 description 2
• 229940049595 antibody-drug conjugate Drugs 0.000 description 2
• 238000002617 apheresis Methods 0.000 description 2
• 230000033228 biological regulation Effects 0.000 description 2
• 239000000090 biomarker Substances 0.000 description 2
• 230000037396 body weight Effects 0.000 description 2
• 210000001185 bone marrow Anatomy 0.000 description 2
• HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
• 210000004899 c-terminal region Anatomy 0.000 description 2
• 238000012512 characterization method Methods 0.000 description 2
• 230000009920 chelation Effects 0.000 description 2
• 238000006243 chemical reaction Methods 0.000 description 2
• 210000003690 classically activated macrophage Anatomy 0.000 description 2
• 238000003776 cleavage reaction Methods 0.000 description 2
• 238000011260 co-administration Methods 0.000 description 2
• NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 2
• 235000018417 cysteine Nutrition 0.000 description 2
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
• 231100000433 cytotoxic Toxicity 0.000 description 2
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 2
• 230000001472 cytotoxic effect Effects 0.000 description 2
• 239000005547 deoxyribonucleotide Substances 0.000 description 2
• 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
• 230000002255 enzymatic effect Effects 0.000 description 2
• 150000002148 esters Chemical class 0.000 description 2
• 238000013467 fragmentation Methods 0.000 description 2
• 238000006062 fragmentation reaction Methods 0.000 description 2
• 125000002446 fucosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)[C@@H](O1)C)* 0.000 description 2
• 101150023212 fut8 gene Proteins 0.000 description 2
• 238000011194 good manufacturing practice Methods 0.000 description 2
• 229920000669 heparin Polymers 0.000 description 2
• 229960002897 heparin Drugs 0.000 description 2
• FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
• 102000055229 human IL4 Human genes 0.000 description 2
• 102000052622 human IL7 Human genes 0.000 description 2
• 229920002674 hyaluronan Polymers 0.000 description 2
• 229960003160 hyaluronic acid Drugs 0.000 description 2
• 229940050526 hydroxyethylstarch Drugs 0.000 description 2
• 230000028993 immune response Effects 0.000 description 2
• 230000001976 improved effect Effects 0.000 description 2
• 230000001939 inductive effect Effects 0.000 description 2
• 108040002039 interleukin-15 receptor activity proteins Proteins 0.000 description 2
• 102000008616 interleukin-15 receptor activity proteins Human genes 0.000 description 2
• 108040006849 interleukin-2 receptor activity proteins Proteins 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 210000001165 lymph node Anatomy 0.000 description 2
• 238000002703 mutagenesis Methods 0.000 description 2
• 229950006780 n-acetylglucosamine Drugs 0.000 description 2
• 210000004897 n-terminal region Anatomy 0.000 description 2
• 229910052757 nitrogen Inorganic materials 0.000 description 2
• RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 230000036961 partial effect Effects 0.000 description 2
• 230000003285 pharmacodynamic effect Effects 0.000 description 2
• 230000000144 pharmacologic effect Effects 0.000 description 2
• 230000004962 physiological condition Effects 0.000 description 2
• 229920000765 poly(2-oxazolines) Polymers 0.000 description 2
• 229920001451 polypropylene glycol Polymers 0.000 description 2
• 229920001282 polysaccharide Polymers 0.000 description 2
• 239000005017 polysaccharide Substances 0.000 description 2
• 230000004481 post-translational protein modification Effects 0.000 description 2
• 230000003389 potentiating effect Effects 0.000 description 2
• QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 2
• 235000019260 propionic acid Nutrition 0.000 description 2
• IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
• 230000001603 reducing effect Effects 0.000 description 2
• 125000002652 ribonucleotide group Chemical group 0.000 description 2
• 230000007017 scission Effects 0.000 description 2
• 230000011664 signaling Effects 0.000 description 2
• 125000006850 spacer group Chemical group 0.000 description 2
• 235000000346 sugar Nutrition 0.000 description 2
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 2
• 231100000419 toxicity Toxicity 0.000 description 2
• 230000001988 toxicity Effects 0.000 description 2
• 229960004441 tyrosine Drugs 0.000 description 2
• FUOJEDZPVVDXHI-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 5-azido-2-nitrobenzoate Chemical compound [O-][N+](=O)C1=CC=C(N=[N+]=[N-])C=C1C(=O)ON1C(=O)CCC1=O FUOJEDZPVVDXHI-UHFFFAOYSA-N 0.000 description 1
• FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 description 1
• AGGWFDNPHKLBBV-YUMQZZPRSA-N (2s)-2-[[(2s)-2-amino-3-methylbutanoyl]amino]-5-(carbamoylamino)pentanoic acid Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=O AGGWFDNPHKLBBV-YUMQZZPRSA-N 0.000 description 1
• YYTDJPUFAVPHQA-VKHMYHEASA-N (2s)-2-amino-3-(2,3,4,5,6-pentafluorophenyl)propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=C(F)C(F)=C(F)C(F)=C1F YYTDJPUFAVPHQA-VKHMYHEASA-N 0.000 description 1
• PEMUHKUIQHFMTH-QMMMGPOBSA-N (2s)-2-amino-3-(4-bromophenyl)propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(Br)C=C1 PEMUHKUIQHFMTH-QMMMGPOBSA-N 0.000 description 1
• JSXMFBNJRFXRCX-NSHDSACASA-N (2s)-2-amino-3-(4-prop-2-ynoxyphenyl)propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(OCC#C)C=C1 JSXMFBNJRFXRCX-NSHDSACASA-N 0.000 description 1
• BJOQKIKXKGJLIJ-NSHDSACASA-N (2s)-2-amino-3-(4-prop-2-ynylphenyl)propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(CC#C)C=C1 BJOQKIKXKGJLIJ-NSHDSACASA-N 0.000 description 1
• NEMHIKRLROONTL-QMMMGPOBSA-N (2s)-2-azaniumyl-3-(4-azidophenyl)propanoate Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N=[N+]=[N-])C=C1 NEMHIKRLROONTL-QMMMGPOBSA-N 0.000 description 1
• ZXSBHXZKWRIEIA-JTQLQIEISA-N (2s)-3-(4-acetylphenyl)-2-azaniumylpropanoate Chemical compound CC(=O)C1=CC=C(C[C@H](N)C(O)=O)C=C1 ZXSBHXZKWRIEIA-JTQLQIEISA-N 0.000 description 1
• VOTJUWBJENROFB-UHFFFAOYSA-N 1-[3-[[3-(2,5-dioxo-3-sulfopyrrolidin-1-yl)oxy-3-oxopropyl]disulfanyl]propanoyloxy]-2,5-dioxopyrrolidine-3-sulfonic acid Chemical compound O=C1C(S(=O)(=O)O)CC(=O)N1OC(=O)CCSSCCC(=O)ON1C(=O)C(S(O)(=O)=O)CC1=O VOTJUWBJENROFB-UHFFFAOYSA-N 0.000 description 1
• VCRPKWLNHWPCSR-UHFFFAOYSA-N 1-diazonio-3-(4-nitrophenoxy)-3-oxoprop-1-en-2-olate Chemical compound [O-][N+](=O)C1=CC=C(OC(=O)C(=O)C=[N+]=[N-])C=C1 VCRPKWLNHWPCSR-UHFFFAOYSA-N 0.000 description 1
• KHAWDEWNXJIVCJ-UHFFFAOYSA-N 1-fluoro-4-(4-fluoro-3-nitrophenyl)sulfonyl-2-nitrobenzene Chemical compound C1=C(F)C([N+](=O)[O-])=CC(S(=O)(=O)C=2C=C(C(F)=CC=2)[N+]([O-])=O)=C1 KHAWDEWNXJIVCJ-UHFFFAOYSA-N 0.000 description 1
• GNENVASJJIUNER-UHFFFAOYSA-N 2,4,6-tricyclohexyloxy-1,3,5,2,4,6-trioxatriborinane Chemical compound C1CCCCC1OB1OB(OC2CCCCC2)OB(OC2CCCCC2)O1 GNENVASJJIUNER-UHFFFAOYSA-N 0.000 description 1
• ASNTZYQMIUCEBV-UHFFFAOYSA-N 2,5-dioxo-1-[6-[3-(pyridin-2-yldisulfanyl)propanoylamino]hexanoyloxy]pyrrolidine-3-sulfonic acid Chemical compound O=C1C(S(=O)(=O)O)CC(=O)N1OC(=O)CCCCCNC(=O)CCSSC1=CC=CC=N1 ASNTZYQMIUCEBV-UHFFFAOYSA-N 0.000 description 1
• JDEYYCJOIRKTCS-UHFFFAOYSA-N 2,5-dioxopyrrolidine-3-sulfonic acid;octanedioic acid Chemical compound OS(=O)(=O)C1CC(=O)NC1=O.OS(=O)(=O)C1CC(=O)NC1=O.OC(=O)CCCCCCC(O)=O JDEYYCJOIRKTCS-UHFFFAOYSA-N 0.000 description 1
• GGBIMBICBVPVDL-UHFFFAOYSA-N 2-(propyldisulfanyl)pyridine Chemical compound CCCSSC1=CC=CC=N1 GGBIMBICBVPVDL-UHFFFAOYSA-N 0.000 description 1
• SHKUUQIDMUMQQK-UHFFFAOYSA-N 2-[4-(oxiran-2-ylmethoxy)butoxymethyl]oxirane Chemical compound C1OC1COCCCCOCC1CO1 SHKUUQIDMUMQQK-UHFFFAOYSA-N 0.000 description 1
• VKUYLANQOAKALN-UHFFFAOYSA-N 2-[benzyl-(4-methoxyphenyl)sulfonylamino]-n-hydroxy-4-methylpentanamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N(C(CC(C)C)C(=O)NO)CC1=CC=CC=C1 VKUYLANQOAKALN-UHFFFAOYSA-N 0.000 description 1
• YVYRKTXQJJKRJG-UHFFFAOYSA-N 2-iodo-n-[6-[(2-iodoacetyl)amino]hexyl]acetamide Chemical compound ICC(=O)NCCCCCCNC(=O)CI YVYRKTXQJJKRJG-UHFFFAOYSA-N 0.000 description 1
• WBGKAOURNYRYBT-UHFFFAOYSA-N 2-sulfopropanoic acid Chemical compound OC(=O)C(C)S(O)(=O)=O WBGKAOURNYRYBT-UHFFFAOYSA-N 0.000 description 1
• NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical compound C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 1
• JMUAKWNHKQBPGJ-UHFFFAOYSA-N 3-(pyridin-2-yldisulfanyl)-n-[4-[3-(pyridin-2-yldisulfanyl)propanoylamino]butyl]propanamide Chemical compound C=1C=CC=NC=1SSCCC(=O)NCCCCNC(=O)CCSSC1=CC=CC=N1 JMUAKWNHKQBPGJ-UHFFFAOYSA-N 0.000 description 1
• NITXODYAMWZEJY-UHFFFAOYSA-N 3-(pyridin-2-yldisulfanyl)propanehydrazide Chemical compound NNC(=O)CCSSC1=CC=CC=N1 NITXODYAMWZEJY-UHFFFAOYSA-N 0.000 description 1
• OEOCGLHNKJKVBF-UHFFFAOYSA-N 3-benzyl-1-hydroxypyrrolidine-2,5-dione Chemical compound O=C1N(O)C(=O)CC1CC1=CC=CC=C1 OEOCGLHNKJKVBF-UHFFFAOYSA-N 0.000 description 1
• JZRBSTONIYRNRI-VIFPVBQESA-N 3-methylphenylalanine Chemical compound CC1=CC=CC(C[C@H](N)C(O)=O)=C1 JZRBSTONIYRNRI-VIFPVBQESA-N 0.000 description 1
• IRZQDMYEJPNDEN-UHFFFAOYSA-N 3-phenyl-2-aminobutanoic acid Natural products OC(=O)C(N)C(C)C1=CC=CC=C1 IRZQDMYEJPNDEN-UHFFFAOYSA-N 0.000 description 1
• LAEUQSVCOOXLEE-UHFFFAOYSA-N 4-[(2-iodoacetyl)amino]benzoic acid Chemical compound OC(=O)C1=CC=C(NC(=O)CI)C=C1 LAEUQSVCOOXLEE-UHFFFAOYSA-N 0.000 description 1
• ZMRMMAOBSFSXLN-UHFFFAOYSA-N 4-[4-(2,5-dioxopyrrol-1-yl)phenyl]butanehydrazide Chemical compound C1=CC(CCCC(=O)NN)=CC=C1N1C(=O)C=CC1=O ZMRMMAOBSFSXLN-UHFFFAOYSA-N 0.000 description 1
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• CMUHFUGDYMFHEI-QMMMGPOBSA-N 4-amino-L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N)C=C1 CMUHFUGDYMFHEI-QMMMGPOBSA-N 0.000 description 1
• YRLKXQVDEQEYSN-UHFFFAOYSA-N 4-azidobenzohydrazide Chemical compound NNC(=O)C1=CC=C(N=[N+]=[N-])C=C1 YRLKXQVDEQEYSN-UHFFFAOYSA-N 0.000 description 1
• PZNQZSRPDOEBMS-QMMMGPOBSA-N 4-iodo-L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(I)C=C1 PZNQZSRPDOEBMS-QMMMGPOBSA-N 0.000 description 1
• 101710151806 72 kDa type IV collagenase Proteins 0.000 description 1
• 108091007504 ADAM10 Proteins 0.000 description 1
• 108091007507 ADAM12 Proteins 0.000 description 1
• 102000029750 ADAMTS Human genes 0.000 description 1
• 108091022879 ADAMTS Proteins 0.000 description 1
• 206010069754 Acquired gene mutation Diseases 0.000 description 1
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
• 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 101710146120 Alpha-(1,6)-fucosyltransferase Proteins 0.000 description 1
• 229920000856 Amylose Polymers 0.000 description 1
• 241000180579 Arca Species 0.000 description 1
• 102100021631 B-cell lymphoma 6 protein Human genes 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
• GPBFJOJPPZBEEX-UHFFFAOYSA-N C(=O)(O)C(O)C(O)C(=O)O.S(=O)(=O)(O)C1C(C(=O)NC1=O)S(=O)(=O)O Chemical compound C(=O)(O)C(O)C(O)C(=O)O.S(=O)(=O)(O)C1C(C(=O)NC1=O)S(=O)(=O)O GPBFJOJPPZBEEX-UHFFFAOYSA-N 0.000 description 1
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
• 101150077194 CAP1 gene Proteins 0.000 description 1
• 101150014715 CAP2 gene Proteins 0.000 description 1
• 108010059108 CD18 Antigens Proteins 0.000 description 1
• 101100112922 Candida albicans CDR3 gene Proteins 0.000 description 1
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
• 102000003908 Cathepsin D Human genes 0.000 description 1
• 108090000258 Cathepsin D Proteins 0.000 description 1
• 108090000625 Cathepsin K Proteins 0.000 description 1
• 102000004171 Cathepsin K Human genes 0.000 description 1
• 108090000613 Cathepsin S Proteins 0.000 description 1
• 102100035654 Cathepsin S Human genes 0.000 description 1
• 239000004971 Cross linker Substances 0.000 description 1
• 102220473613 Cytochrome b5_R67A_mutation Human genes 0.000 description 1
• FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 description 1
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
• 229920001353 Dextrin Polymers 0.000 description 1
• 239000004375 Dextrin Substances 0.000 description 1
• 102100039673 Disintegrin and metalloproteinase domain-containing protein 10 Human genes 0.000 description 1
• 102100031112 Disintegrin and metalloproteinase domain-containing protein 12 Human genes 0.000 description 1
• 102000016662 ELAV Proteins Human genes 0.000 description 1
• 108010053101 ELAV Proteins Proteins 0.000 description 1
• 238000002965 ELISA Methods 0.000 description 1
• 241000214054 Equine rhinitis A virus Species 0.000 description 1
• 102000003951 Erythropoietin Human genes 0.000 description 1
• 241000588724 Escherichia coli Species 0.000 description 1
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
• 108010088842 Fibrinolysin Proteins 0.000 description 1
• 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
• 102000006471 Fucosyltransferases Human genes 0.000 description 1
• 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 description 1
• SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
• BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 102000051366 Glycosyltransferases Human genes 0.000 description 1
• 108700023372 Glycosyltransferases Proteins 0.000 description 1
• 206010066476 Haematological malignancy Diseases 0.000 description 1
• SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
• 208000017604 Hodgkin disease Diseases 0.000 description 1
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
• 101000819490 Homo sapiens Alpha-(1,6)-fucosyltransferase Proteins 0.000 description 1
• 101000971234 Homo sapiens B-cell lymphoma 6 protein Proteins 0.000 description 1
• 101100005713 Homo sapiens CD4 gene Proteins 0.000 description 1
• 101000987586 Homo sapiens Eosinophil peroxidase Proteins 0.000 description 1
• 101000920686 Homo sapiens Erythropoietin Proteins 0.000 description 1
• 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 description 1
• 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 1
• 101000976075 Homo sapiens Insulin Proteins 0.000 description 1
• 101000615488 Homo sapiens Methyl-CpG-binding domain protein 2 Proteins 0.000 description 1
• 101000622137 Homo sapiens P-selectin Proteins 0.000 description 1
• 101000872170 Homo sapiens Polycomb complex protein BMI-1 Proteins 0.000 description 1
• 101000687438 Homo sapiens Prolactin Proteins 0.000 description 1
• 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 description 1
• 101001050288 Homo sapiens Transcription factor Jun Proteins 0.000 description 1
• NRSPOJRMDVHRCX-UHFFFAOYSA-N IC=1C(C(C=CC1C)(C)S(=O)(=O)O)I Chemical compound IC=1C(C(C=CC1C)(C)S(=O)(=O)O)I NRSPOJRMDVHRCX-UHFFFAOYSA-N 0.000 description 1
• 108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 1
• 102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 1
• 206010062016 Immunosuppression Diseases 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 102100037850 Interferon gamma Human genes 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• 108010066719 Interleukin Receptor Common gamma Subunit Proteins 0.000 description 1
• 102000018682 Interleukin Receptor Common gamma Subunit Human genes 0.000 description 1
• 108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
• 102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
• WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
• 235000019766 L-Lysine Nutrition 0.000 description 1
• FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 description 1
• 206010052178 Lymphocytic lymphoma Diseases 0.000 description 1
• 206010025323 Lymphomas Diseases 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 108091054438 MHC class II family Proteins 0.000 description 1
• 102000043131 MHC class II family Human genes 0.000 description 1
• PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 1
• 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 1
• 108010076557 Matrix Metalloproteinase 14 Proteins 0.000 description 1
• 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
• 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
• 102100030216 Matrix metalloproteinase-14 Human genes 0.000 description 1
• 102100021299 Methyl-CpG-binding domain protein 2 Human genes 0.000 description 1
• 208000034578 Multiple myelomas Diseases 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 108010021466 Mutant Proteins Proteins 0.000 description 1
• 102000008300 Mutant Proteins Human genes 0.000 description 1
• 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
• 102100032970 Myogenin Human genes 0.000 description 1
• 108010056785 Myogenin Proteins 0.000 description 1
• ABQAYNZTNCGVRM-UHFFFAOYSA-N N(=[N+]=[N-])C1=CC=C(C(=O)O)C=C1.ON1C(C(CC1=O)S(=O)(=O)O)=O Chemical compound N(=[N+]=[N-])C1=CC=C(C(=O)O)C=C1.ON1C(C(CC1=O)S(=O)(=O)O)=O ABQAYNZTNCGVRM-UHFFFAOYSA-N 0.000 description 1
• OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
• OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
• MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
• 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 1
• 101100438378 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) fac-1 gene Proteins 0.000 description 1
• 101100326803 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) fac-2 gene Proteins 0.000 description 1
• 102100030411 Neutrophil collagenase Human genes 0.000 description 1
• 101710118230 Neutrophil collagenase Proteins 0.000 description 1
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
• 102000017954 Nuclear factor of activated T cells (NFAT) Human genes 0.000 description 1
• 108050007058 Nuclear factor of activated T cells (NFAT) Proteins 0.000 description 1
• GEYBMYRBIABFTA-VIFPVBQESA-N O-methyl-L-tyrosine Chemical compound COC1=CC=C(C[C@H](N)C(O)=O)C=C1 GEYBMYRBIABFTA-VIFPVBQESA-N 0.000 description 1
• SUHOOTKUPISOBE-UHFFFAOYSA-N O-phosphoethanolamine Chemical group NCCOP(O)(O)=O SUHOOTKUPISOBE-UHFFFAOYSA-N 0.000 description 1
• 108091034117 Oligonucleotide Proteins 0.000 description 1
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 102100023472 P-selectin Human genes 0.000 description 1
• KHGNFPUMBJSZSM-UHFFFAOYSA-N Perforine Natural products COC1=C2CCC(O)C(CCC(C)(C)O)(OC)C2=NC2=C1C=CO2 KHGNFPUMBJSZSM-UHFFFAOYSA-N 0.000 description 1
• FADYJNXDPBKVCA-STQMWFEESA-N Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 FADYJNXDPBKVCA-STQMWFEESA-N 0.000 description 1
• 229920001389 Poly(hydroxyalkylmethacrylamide) Polymers 0.000 description 1
• 102100033566 Polycomb complex protein BMI-1 Human genes 0.000 description 1
• 229920001100 Polydextrose Polymers 0.000 description 1
• 108010071690 Prealbumin Proteins 0.000 description 1
• 101710180319 Protease 1 Proteins 0.000 description 1
• 101710180316 Protease 2 Proteins 0.000 description 1
• 101710180313 Protease 3 Proteins 0.000 description 1
• 101710180309 Protease 4 Proteins 0.000 description 1
• 101710180012 Protease 7 Proteins 0.000 description 1
• 108091027981 Response element Proteins 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 102100030416 Stromelysin-1 Human genes 0.000 description 1
• 101710108790 Stromelysin-1 Proteins 0.000 description 1
• 230000024932 T cell mediated immunity Effects 0.000 description 1
• 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 description 1
• 101710137710 Thioesterase 1/protease 1/lysophospholipase L1 Proteins 0.000 description 1
• 108091036066 Three prime untranslated region Proteins 0.000 description 1
• 101001023030 Toxoplasma gondii Myosin-D Proteins 0.000 description 1
• 102100023132 Transcription factor Jun Human genes 0.000 description 1
• 102000004357 Transferases Human genes 0.000 description 1
• 108090000992 Transferases Proteins 0.000 description 1
• 102000004338 Transferrin Human genes 0.000 description 1
• 108090000901 Transferrin Proteins 0.000 description 1
• 102000009190 Transthyretin Human genes 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102100040247 Tumor necrosis factor Human genes 0.000 description 1
• 102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 description 1
• 101710181056 Tumor necrosis factor ligand superfamily member 13B Proteins 0.000 description 1
• HSRXSKHRSXRCFC-WDSKDSINSA-N Val-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(O)=O HSRXSKHRSXRCFC-WDSKDSINSA-N 0.000 description 1
• JKHXYJKMNSSFFL-IUCAKERBSA-N Val-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN JKHXYJKMNSSFFL-IUCAKERBSA-N 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 239000003070 absorption delaying agent Substances 0.000 description 1
• PZAGQUOSOTUKEC-UHFFFAOYSA-N acetic acid;sulfuric acid Chemical compound CC(O)=O.OS(O)(=O)=O PZAGQUOSOTUKEC-UHFFFAOYSA-N 0.000 description 1
• 229960005305 adenosine Drugs 0.000 description 1
• IBVAQQYNSHJXBV-UHFFFAOYSA-N adipic acid dihydrazide Chemical compound NNC(=O)CCCCC(=O)NN IBVAQQYNSHJXBV-UHFFFAOYSA-N 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 229940050528 albumin Drugs 0.000 description 1
• 150000001299 aldehydes Chemical class 0.000 description 1
• 150000001335 aliphatic alkanes Chemical class 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• 230000000735 allogeneic effect Effects 0.000 description 1
• WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
• 229940025084 amphetamine Drugs 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000000844 anti-bacterial effect Effects 0.000 description 1
• 230000006023 anti-tumor response Effects 0.000 description 1
• 239000000611 antibody drug conjugate Substances 0.000 description 1
• 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 1
• 239000003429 antifungal agent Substances 0.000 description 1
• 229940121375 antifungal agent Drugs 0.000 description 1
• 150000001502 aryl halides Chemical class 0.000 description 1
• 238000003556 assay Methods 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• 210000003651 basophil Anatomy 0.000 description 1
• HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
• DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
• SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
• 230000001588 bifunctional effect Effects 0.000 description 1
• 230000015572 biosynthetic process Effects 0.000 description 1
• 210000001772 blood platelet Anatomy 0.000 description 1
• 239000001273 butane Substances 0.000 description 1
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 239000006227 byproduct Substances 0.000 description 1
• 230000009400 cancer invasion Effects 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 231100000504 carcinogenesis Toxicity 0.000 description 1
• 238000000423 cell based assay Methods 0.000 description 1
• 230000011712 cell development Effects 0.000 description 1
• 230000012292 cell migration Effects 0.000 description 1
• 230000004663 cell proliferation Effects 0.000 description 1
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
• BFPSDSIWYFKGBC-UHFFFAOYSA-N chlorotrianisene Chemical compound C1=CC(OC)=CC=C1C(Cl)=C(C=1C=CC(OC)=CC=1)C1=CC=C(OC)C=C1 BFPSDSIWYFKGBC-UHFFFAOYSA-N 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 230000004154 complement system Effects 0.000 description 1
• 230000001010 compromised effect Effects 0.000 description 1
• 230000003750 conditioning effect Effects 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 229920001577 copolymer Polymers 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 230000006240 deamidation Effects 0.000 description 1
• 230000022811 deglycosylation Effects 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 229950006137 dexfosfoserine Drugs 0.000 description 1
• 235000019425 dextrin Nutrition 0.000 description 1
• LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 1
• 239000012969 di-tertiary-butyl peroxide Substances 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• 239000002612 dispersion medium Substances 0.000 description 1
• 230000008030 elimination Effects 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 150000002085 enols Chemical class 0.000 description 1
• 210000003979 eosinophil Anatomy 0.000 description 1
• 210000002919 epithelial cell Anatomy 0.000 description 1
• 229940105423 erythropoietin Drugs 0.000 description 1
• 125000004494 ethyl ester group Chemical group 0.000 description 1
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 238000002474 experimental method Methods 0.000 description 1
• 210000002744 extracellular matrix Anatomy 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 230000037433 frameshift Effects 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• 229930182830 galactose Natural products 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 238000007429 general method Methods 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• JFCQEDHGNNZCLN-UHFFFAOYSA-N glutaric acid Chemical compound OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
• 125000003147 glycosyl group Chemical group 0.000 description 1
• 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 1
• 230000003394 haemopoietic effect Effects 0.000 description 1
• 210000002443 helper t lymphocyte Anatomy 0.000 description 1
• 208000019691 hematopoietic and lymphoid cell neoplasm Diseases 0.000 description 1
• 239000000833 heterodimer Substances 0.000 description 1
• 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 229960001340 histamine Drugs 0.000 description 1
• 210000003630 histaminocyte Anatomy 0.000 description 1
• 230000007236 host immunity Effects 0.000 description 1
• 230000028996 humoral immune response Effects 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 229940127121 immunoconjugate Drugs 0.000 description 1
• 238000009169 immunotherapy Methods 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 239000012535 impurity Substances 0.000 description 1
• 238000000099 in vitro assay Methods 0.000 description 1
• 230000001965 increasing effect Effects 0.000 description 1
• 229940060367 inert ingredients Drugs 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 229960000367 inositol Drugs 0.000 description 1
• CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
• 238000003780 insertion Methods 0.000 description 1
• 230000037431 insertion Effects 0.000 description 1
• PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 1
• 229960003130 interferon gamma Drugs 0.000 description 1
• 229940028885 interleukin-4 Drugs 0.000 description 1
• 229940100994 interleukin-7 Drugs 0.000 description 1
• 210000000936 intestine Anatomy 0.000 description 1
• PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 230000004807 localization Effects 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 210000004324 lymphatic system Anatomy 0.000 description 1
• 210000003563 lymphoid tissue Anatomy 0.000 description 1
• 235000018977 lysine Nutrition 0.000 description 1
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 238000002826 magnetic-activated cell sorting Methods 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 230000010534 mechanism of action Effects 0.000 description 1
• 239000002207 metabolite Substances 0.000 description 1
• 230000009401 metastasis Effects 0.000 description 1
• WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 229960004452 methionine Drugs 0.000 description 1
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• ODTZGFFHYPHJNS-UHFFFAOYSA-N n-(4-benzoylphenyl)-2-iodoacetamide Chemical compound C1=CC(NC(=O)CI)=CC=C1C(=O)C1=CC=CC=C1 ODTZGFFHYPHJNS-UHFFFAOYSA-N 0.000 description 1
• IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
• OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
• 210000000581 natural killer T-cell Anatomy 0.000 description 1
• 230000010309 neoplastic transformation Effects 0.000 description 1
• JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 1
• 239000002777 nucleoside Substances 0.000 description 1
• 125000003835 nucleoside group Chemical group 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• 239000002751 oligonucleotide probe Substances 0.000 description 1
• 229950002610 otelixizumab Drugs 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 125000006353 oxyethylene group Chemical group 0.000 description 1
• 210000002741 palatine tonsil Anatomy 0.000 description 1
• 229960000402 palivizumab Drugs 0.000 description 1
• 229930192851 perforin Natural products 0.000 description 1
• 210000004976 peripheral blood cell Anatomy 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
• 230000001766 physiological effect Effects 0.000 description 1
• 229940012957 plasmin Drugs 0.000 description 1
• 230000004983 pleiotropic effect Effects 0.000 description 1
• 229920001390 poly(hydroxyalkylmethacrylate) Polymers 0.000 description 1
• 229920001583 poly(oxyethylated polyols) Polymers 0.000 description 1
• 229920002627 poly(phosphazenes) Polymers 0.000 description 1
• 229920001481 poly(stearyl methacrylate) Polymers 0.000 description 1
• 229920000768 polyamine Polymers 0.000 description 1
• 239000001259 polydextrose Substances 0.000 description 1
• 235000013856 polydextrose Nutrition 0.000 description 1
• 229940035035 polydextrose Drugs 0.000 description 1
• 102000040430 polynucleotide Human genes 0.000 description 1
• 108091033319 polynucleotide Proteins 0.000 description 1
• 239000002157 polynucleotide Substances 0.000 description 1
• 229920002451 polyvinyl alcohol Polymers 0.000 description 1
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 229940002612 prodrug Drugs 0.000 description 1
• 239000000651 prodrug Substances 0.000 description 1
• DXGIRFAFSFKYCF-UHFFFAOYSA-N propanehydrazide Chemical compound CCC(=O)NN DXGIRFAFSFKYCF-UHFFFAOYSA-N 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 235000019419 proteases Nutrition 0.000 description 1
• 108020001580 protein domains Proteins 0.000 description 1
• 238000010298 pulverizing process Methods 0.000 description 1
• 238000002708 random mutagenesis Methods 0.000 description 1
• 229940044551 receptor antagonist Drugs 0.000 description 1
• 239000002464 receptor antagonist Substances 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
• 229910000058 selane Inorganic materials 0.000 description 1
• 229940055619 selenocysteine Drugs 0.000 description 1
• ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 1
• 235000016491 selenocysteine Nutrition 0.000 description 1
• 229960001153 serine Drugs 0.000 description 1
• SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
• 102000035025 signaling receptors Human genes 0.000 description 1
• 108091005475 signaling receptors Proteins 0.000 description 1
• 238000002741 site-directed mutagenesis Methods 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 239000000243 solution Substances 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 230000000392 somatic effect Effects 0.000 description 1
• 230000037439 somatic mutation Effects 0.000 description 1
• 230000009870 specific binding Effects 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 210000002536 stromal cell Anatomy 0.000 description 1
• TYFQFVWCELRYAO-UHFFFAOYSA-L suberate(2-) Chemical compound [O-]C(=O)CCCCCCC([O-])=O TYFQFVWCELRYAO-UHFFFAOYSA-L 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
• 230000003319 supportive effect Effects 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 229940095064 tartrate Drugs 0.000 description 1
• 229950010127 teplizumab Drugs 0.000 description 1
• 238000012360 testing method Methods 0.000 description 1
• 210000001541 thymus gland Anatomy 0.000 description 1
• 230000009258 tissue cross reactivity Effects 0.000 description 1
• 239000012581 transferrin Substances 0.000 description 1
• 238000011830 transgenic mouse model Methods 0.000 description 1
• 230000005945 translocation Effects 0.000 description 1
• 238000011269 treatment regimen Methods 0.000 description 1
• 230000004614 tumor growth Effects 0.000 description 1
• 230000001875 tumorinhibitory effect Effects 0.000 description 1
• DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
• 229940045145 uridine Drugs 0.000 description 1
• 229960005486 vaccine Drugs 0.000 description 1
• 108010073969 valyllysine Proteins 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 229950004393 visilizumab Drugs 0.000 description 1
• 238000011179 visual inspection Methods 0.000 description 1
• JPZXHKDZASGCLU-LBPRGKRZSA-N β-(2-naphthyl)-alanine Chemical compound C1=CC=CC2=CC(C[C@H](N)C(O)=O)=CC=C21 JPZXHKDZASGCLU-LBPRGKRZSA-N 0.000 description 1